ANDI
Automated Neurodegeneration Index
A prognostic marker that quantifies and tracks neurodegeneration over time—designed to optimize clinical trial outcomes.
How does ANDI Neurodegeneration work?
ANDI neurodegeneration index is a numerical marker derived from diffusion MRI scans that indicates the level of neurodegeneration.
Free-Water Imaging Analysis
ANDI neurodegeneration analysis is based on Free-Water Imaging (FWI), which is a powerful enhancement to diffusion MRI scan processing techniques that separates true brain tissue signal from excess extracellular water.
Sharper microstructural insight
Measures severity, rate, and state of degeneration.
Predict rates of progression
Detects subtle microstructural changes between closer timepoints, beyond what volumetric imaging sees.
Quantify and monitor treatment responses
Improves outcomes for healthcare and clinical trials.
96%
Up to 96% accuracy
21 sites
involved in most recent clinical trial
15+
Years of data collected
1000+
Unique datasets analyzed
Exclusive, Patented Technology
neuropacs™ leverages proprietary, patent-protected techniques that combine:
- AI-driven diagnostics trained on harmonized multi-site data
- Exclusively licensed with Patent pending.
- Free-Water Imaging (FWI): A powerful diffusion MRI method that enhances early disease detection
Comprehensive Toolset
Delivered via secure cloud-based workflow
Whether supporting clinical decision-making or powering trial success, neuropacs™ provides exclusive methodologies, actionable insights, and a seamless integration into existing imaging workflows.
Ready to improve your outcomes using our precision AI platform?
Our dedicated team can help you determine which neuropacs™ solution best fits your clinical or research needs.